Coinhibitory pathways in the B7-CD28 ligand-receptor family

FA Schildberg, SR Klein, GJ Freeman, AH Sharpe - Immunity, 2016 - cell.com
Immune responses need to be controlled for optimal protective immunity and tolerance.
Coinhibitory pathways in the B7-CD28 family provide critical inhibitory signals that regulate …

Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights

A Faje - Pituitary, 2016 - Springer
Introduction Advances in immunotherapy have transformed the management of metastatic
melanoma and generated encouraging results in the treatment of other malignancies …

Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody

S Iwama, A De Remigis, MK Callahan… - Science translational …, 2014 - science.org
Hypophysitis is a chronic inflammation of the pituitary gland of unknown (primary forms) or
recognizable (secondary forms) etiology, such as the use of ipilimumab in cancer …

Beyond T-cells: functional characterization of CTLA-4 expression in immune and non-immune cell types

D Oyewole-Said, V Konduri, J Vazquez-Perez… - Frontiers in …, 2020 - frontiersin.org
The immune response consists of a finely-tuned program, the activation of which must be
coupled with inhibitory mechanisms whenever initiated. This ensures tight control of …

Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies

H Wang, G Kaur, AI Sankin, F Chen, F Guan… - Journal of hematology & …, 2019 - Springer
Harnessing the power of the immune system to recognize and eliminate cancer cells is a
longtime exploration. In the past decade, monoclonal antibody (mAb)-based immune …

Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer

JW Kim, KH Nam, SH Ahn, DJ Park, HH Kim, SH Kim… - Gastric cancer, 2016 - Springer
Background There are few data on the clinical implications of immunosuppressive protein
expression in tumors and immune cell infiltration within the tumor microenvironment in …

Evolving roles for targeting CTLA-4 in cancer immunotherapy

Y Zhao, W Yang, Y Huang, R Cui, X Li… - Cellular Physiology and …, 2018 - karger.com
Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) is a membrane glycoprotein
expressed by activated effector T cells (Teffs) and participates in the repression of T cell …

A molecular perspective of CTLA-4 function

WA Teft, MG Kirchhof, J Madrenas - Annu. Rev. Immunol., 2006 - annualreviews.org
Within the paradigm of the two-signal model of lymphocyte activation, the interest in
costimulation has witnessed a remarkable emergence in the past few years with the …

CTLA‐4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction

E Contardi, GL Palmisano, PL Tazzari… - … journal of cancer, 2005 - Wiley Online Library
Abstract CTLA‐4 (CD152) is a cell surface receptor that behaves as a negative regulator of
the proliferation and the effector function of T cells. We have previously shown that CTLA‐4 …

Immunotoxins for targeted cancer therapy

RJ Kreitman - The AAPS journal, 2006 - Springer
Immunotoxins are proteins that contain a toxin along with an antibody or growth factor that
binds specifically to target cells. Nearly all protein toxins work by enzymatically inhibiting …